Tayside Immunology Group & CSI Division Seminar
Dr Susanne Heinzel is a senior research scientist at the Walter and Elisa Hall Institute for Medical Research, Melbourne, Australia and the President of the Australasian Society for Immunology. She completed her PhD at the University in Tuebingen in Germany in the field of Tumour Immunology before moving to Adelaide, Australia where she continued to research in that field. From 2006-2010 she joined Vaxine a small biotech company in Adelaide where she worked as clinical trial manager and senior research scientist on the development of vaccine adjuvants.
Her research focuses on the quantitative analysis of the rules that govern the activation, survival and expansion of T and B lymphocytes in health and disease. She is an expert in the analysis of cell fate regulation. She has discovered that the oncogene Myc controls the cell division of activated lymphocytes in a time dependent manner. Her recent work has been published in journals such as Science, Nat Immunology, Nat Comms, JI and PNAS.